N-(2-キノキサリニルカルボニル)シクロ(D-Ser*-Ala-N-メチル-L-Cys(1)-N-メチル-L-Val-N-(キノキサリン-2-イルカルボニル)-D-Ser*-Ala-N-メチル-3-メチルチオ-L-Ala(1)-N-メチル-L-Val-)

N-(2-キノキサリニルカルボニル)シクロ(D-Ser*-Ala-N-メチル-L-Cys(1)-N-メチル-L-Val-N-(キノキサリン-2-イルカルボニル)-D-Ser*-Ala-N-メチル-3-メチルチオ-L-Ala(1)-N-メチル-L-Val-) 価格 もっと(3)

メーカー	製品番号	製品説明	CAS番号	包装	価格	更新時間	購入
富士フイルム和光純薬株式会社(wako)	W01TOC5520	Echinomycin	512-64-1	1mg	￥41000	2024-03-01	購入
Sigma-Aldrich Japan	SML0477	エキノマイシン ≥98% (HPLC) Echinomycin ≥98% (HPLC)	512-64-1	1mg	￥33300	2024-03-01	購入
Sigma-Aldrich Japan	SML0477	エキノマイシン ≥98% (HPLC) Echinomycin ≥98% (HPLC)	512-64-1	5mg	￥85300	2024-03-01	購入

N-(2-キノキサリニルカルボニル)シクロ(D-Ser*-Ala-N-メチル-L-Cys(1)-N-メチル-L-Val-N-(キノキサリン-2-イルカルボニル)-D-Ser*-Ala-N-メチル-3-メチルチオ-L-Ala(1)-N-メチル-L-Val-) 化学特性,用途語,生産方法

説明

Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that controls genes involved in glycolysis, angiogenesis, migration, and invasion. Echinomycin is a cell-permeable inhibitor of HIF-1-mediated gene transcription. It acts by intercalating into DNA in a sequence-specific manner, blocking the binding of either HIF-1α or HIF-1β to the hypoxia-responsive element. Echinomycin reversibly inhibits hypoxia-induced HIF-1 transcription activity in U215 cells with an EC₅₀ value of 1.2 nM. It inhibits hypoxia-induced expression of vascular endothelial growth factor, blocking angiogenesis and altering excitatory synaptic transmission in hippocampal neurons. Echinomycin also impairs expression of survivin, enhancing the sensitivity of multiple myeloma cells to melphalan.

使用

Quiniomycin A is a cyclic depsipeptide metabolite. Quinomycin A has broad activity against bacteria, fungi and viruses, and has found application as an antitumour agent. Quinomycin A acts by bifunctional intercalation of nucleic acids. Recent research has shown quinomycin A to be an extremely potent inhibitor of hypoxia-inducible factor-1 (HIF-1). This transcription factor plays an essential role in tumour progression and metastasis.

Biochem/physiol Actions

Echinomycin is an antitumor antibiotic and potent hypoxia inducible factor 1α (HIF-1α) inhibitor. It binds to DNA via bifunctional intercalation, blocking the binding of HIF-1α, a transcription factor important in tumor growth. Echinomycin selectively eliminated cancer stem cells in a study with mouse lymphoma and human AML xenogeneic models, eradicating the lymphomas. Recently, echinomycin was also found to act as an antibiotic adjuvant having synergistic effects with novobiocin in gram negative bacteria.

N-(2-キノキサリニルカルボニル)シクロ(D-Ser*-Ala-N-メチル-L-Cys(1)-N-メチル-L-Val-N-(キノキサリン-2-イルカルボニル)-D-Ser*-Ala-N-メチル-3-メチルチオ-L-Ala(1)-N-メチル-L-Val-) 上流と下流の製品情報

原材料

準備製品

N-(2-キノキサリニルカルボニル)シクロ(D-Ser*-Ala-N-メチル-L-Cys(1)-N-メチル-L-Val-N-(キノキサリン-2-イルカルボニル)-D-Ser*-Ala-N-メチル-3-メチルチオ-L-Ala(1)-N-メチル-L-Val-) 生産企業

名前	電話番号	電子メール	国籍	製品カタログ	優位度
Fuxin Pharmaceutical	+86-021-021-50872116 +8613122107989	contact@fuxinpharm.com	China	10297	58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.	+86-021-61551413 +8618813727289	contact@trustwe.com	China	5738	58
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	19892	58
Zhejiang Huida Biotech Co., LTD	008613515763466 8615669048680	wendy@huidabiotech.com	CHINA	87	58
BOC Sciences	+16314854226	inquiry@bocsci.com	United States	19743	58
Nextpeptide Inc	+86-0571-81612335 +8613336028439	sales@nextpeptide.com	China	19915	58
Alfa Chemistry	+1-5166625404	Info@alfa-chemistry.com	United States	21317	58
Wuhan Topule Biopharmaceutical Co., Ltd	+8618327326525	masar@topule.com	China	8474	58
Shanghai Acmec Biochemical Technology Co., Ltd.	+undefined18621343501	product@acmec-e.com	China	33349	58
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd	+86-19164747840 +86-13119157289	13119157289@163.com	China	2971	58

512-64-1(N-(2-キノキサリニルカルボニル)シクロ(D-Ser*-Ala-N-メチル-L-Cys(1)-N-メチル-L-Val-N-(キノキサリン-2-イルカルボニル)-D-Ser*-Ala-N-メチル-3-メチルチオ-L-Ala(1)-N-メチル-L-Val-))キーワード:

---

• 512-64-1
• echinomycina
• nsc526417
• ECHINOMYCIN
• N-[(1R,4S,8R,11S,14R,17S,21R,24S)-3,11,13,16,24,26-hexamethyl-27-methylsulfanyl-2,5,9,12,15,18,22,25-octaoxo-4,17-di(propan-2-yl)-8-(quinoxaline-2-carbonylamino)-6,19-dioxa-28-thia-3,10,13,16,23,26-hexazabicyclo[12.12.3]nonacosan-21-yl]quinoxaline-2-carbo
• N-(2-Quinoxalinylcarbonyl)cyclo(D-Ser*-Ala-N-methyl-L-Cys(1)-N-methyl-L-Val-N-(quinoxaline-2-ylcarbonyl)-D-Ser*-Ala-N-methyl-3-methylthio-L-Ala(1)-N-methyl-L-Val-)
• SK-302B
• Echinomycin >97%
• N-(2-Quinoxalinylcarbonyl)-O-[N-(2-quinoxalinylcarbonyl)-D-seryl-L-alanyl-3-mercapto-N,S-dimethylcysteinyl-N-methyl-L-valyl]-D-seryl-L-alanyl-N-methylcysteinyl-N-methyl L-valine (81)-lactone cyclic (37)-thioester
• Echinomycin (NSC-13502)
• QUINOMYCIN A
• EchinoMycin, Actinoleukin, 1491, 59266, X 948, X 53III
• 9,22-Dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosane cyclic peptide deriv.
• Antibiotic A 654I
• NSC 13502
• Echinomycin Streptomyces sp. - CAS 512-64-1 - Calbiochem
• N-(2-Quinoxalinylcarbonyl)-O-[N-(2-quinoxalinylcarbonyl)-D-seryl-L-alanyl-3-mercapto-N,S-dimethylcysteinyl-N-methyl-L-valyl]-D-seryl-L-alanyl-N-methylcysteinyl-N-methyl-L-valine-(81)-lactone-cyclic (37)-thioether
• N-[2,4,12,15,17,25-hexamethyl-29-methylsulfanyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-7-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-20-yl]quinoxaline-2-carboxamide
• L-Valine, N-(2-quinoxalinylcarbonyl)-O-[N-(2-quinoxalinylcarbonyl)-D-seryl-L-alanyl-3-mercapto-N,S-dimethylcysteinyl-N-methyl-L-valyl]-D-seryl-L-alanyl-N-methylcysteinyl-N-methyl-, (8→1)-lactone, cyclic (3→7)-thioether
• N-(2-キノキサリニルカルボニル)シクロ(D-Ser*-Ala-N-メチル-L-Cys(1)-N-メチル-L-Val-N-(キノキサリン-2-イルカルボニル)-D-Ser*-Ala-N-メチル-3-メチルチオ-L-Ala(1)-N-メチル-L-Val-)
• エキノマイシン
• キノマイシンA
• N-[(1R,4S,7R,11S,14R,17S,20R,24S)-2,4,12,15,17,25-ヘキサメチル-27-(メチルスルファニル)-3,6,10,13,16,19,23,26-オクタオキソ-11,24-ビス(プロパン-2-イル)-20-(キノキサリン-2-アミド)-9,22-ジオキサ-28-チア-2,5,12,15,18,25-ヘキサアザビシクロ[12.12.3]ノナコサン-7-イル]キノキサリン-2-カルボキサミド
• ペプチド系抗生物質
• 抗腫瘍抗生物質